Skip to main content

Cresset Asset Management, LLC

Position in ZTS — Zoetis Inc.

CIK 1761013 Chicago, IL

Position in ZTS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,485,463
+$4,875,401 QoQ
Shares Held
88,702
+98.9% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98.23002863520553.ToString("F0")% Shared 0.ToString("F0")% None 1.7699713647944804.ToString("F0")%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Mar 31, 2026
CallValue
$4,409,233
CallShares
37,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Cresset Asset Management, LLC holds $16,229,662 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (64.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
This page
88,702 $10,485,463

All Filings in ZTS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,409,233 37,300
2026-03-31 $10,485,463 88,702
2025-12-31 $5,610,062 44,588
2025-09-30 $1,387,406 9,482
2025-06-30 $1,425,227 9,139
2025-03-31 $3,238,665 19,670
2024-12-31 $4,151,293 25,479
2024-09-30 $14,067,358 72,000
2024-06-30 $11,716,014 67,582
2024-03-31 $10,822,671 63,960
2023-12-31 $10,914,363 55,299
2023-09-30 $10,218,715 58,735
2023-06-30 $8,692,471 50,476
2023-03-31 $1,987,127 11,939
2022-12-31 $2,470,246 16,856
2022-09-30 $2,535,759 17,100
2022-06-30 $2,825,527 16,438
2022-03-31 $2,783,022 14,757
2021-12-31 $3,766,847 15,436
2021-09-30 $3,830,770 19,732
2021-06-30 $3,233,346 17,350
2021-03-31 $2,320,625 14,736
2020-12-31 $1,874,453 11,326
2020-09-30 $1,938,467 11,722
2020-06-30 $1,856,480 13,547
2020-03-31 $1,227,977 10,434